Copyright Reports & Markets. All rights reserved.

COVID-19 Impact on Global Ocular Drug Delivery, Market Insights and Forecast to 2026

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Ocular Drug Delivery Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Ocular Drug Delivery Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Ocular Drug Delivery Market Size Growth Rate by Type
    • 1.4.2 Type I
    • 1.4.3 Type II
  • 1.5 Market by Application
    • 1.5.1 Global Ocular Drug Delivery Market Size Growth Rate by Application
    • 1.5.2 Hospitals
    • 1.5.3 Ambulatory Surgical Centers
    • 1.5.4 Ophthalmic Clinics
    • 1.5.5 Homecare Settings
  • 1.6 Coronavirus Disease 2019 (Covid-19): Ocular Drug Delivery Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Ocular Drug Delivery Industry
      • 1.6.1.1 Ocular Drug Delivery Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Ocular Drug Delivery Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Ocular Drug Delivery Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Executive Summary

  • 2.1 Global Ocular Drug Delivery Market Size Estimates and Forecasts
    • 2.1.1 Global Ocular Drug Delivery Revenue 2015-2026
    • 2.1.2 Global Ocular Drug Delivery Sales 2015-2026
  • 2.2 Ocular Drug Delivery Market Size by Region: 2020 Versus 2026
    • 2.2.1 Global Ocular Drug Delivery Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Ocular Drug Delivery Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Ocular Drug Delivery Competitor Landscape by Players

  • 3.1 Ocular Drug Delivery Sales by Manufacturers
    • 3.1.1 Ocular Drug Delivery Sales by Manufacturers (2015-2020)
    • 3.1.2 Ocular Drug Delivery Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Ocular Drug Delivery Revenue by Manufacturers
    • 3.2.1 Ocular Drug Delivery Revenue by Manufacturers (2015-2020)
    • 3.2.2 Ocular Drug Delivery Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Ocular Drug Delivery Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Ocular Drug Delivery Revenue in 2019
    • 3.2.5 Global Ocular Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Ocular Drug Delivery Price by Manufacturers
  • 3.4 Ocular Drug Delivery Manufacturing Base Distribution, Product Types
    • 3.4.1 Ocular Drug Delivery Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Ocular Drug Delivery Product Type
    • 3.4.3 Date of International Manufacturers Enter into Ocular Drug Delivery Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Ocular Drug Delivery Market Size by Type (2015-2020)
    • 4.1.1 Global Ocular Drug Delivery Sales by Type (2015-2020)
    • 4.1.2 Global Ocular Drug Delivery Revenue by Type (2015-2020)
    • 4.1.3 Ocular Drug Delivery Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Ocular Drug Delivery Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Ocular Drug Delivery Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Ocular Drug Delivery Revenue Forecast by Type (2021-2026)
    • 4.2.3 Ocular Drug Delivery Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Ocular Drug Delivery Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Breakdown Data by Application (2015-2026)

  • 5.1 Global Ocular Drug Delivery Market Size by Application (2015-2020)
    • 5.1.1 Global Ocular Drug Delivery Sales by Application (2015-2020)
    • 5.1.2 Global Ocular Drug Delivery Revenue by Application (2015-2020)
    • 5.1.3 Ocular Drug Delivery Price by Application (2015-2020)
  • 5.2 Ocular Drug Delivery Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Ocular Drug Delivery Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Ocular Drug Delivery Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Ocular Drug Delivery Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Ocular Drug Delivery by Country
    • 6.1.1 North America Ocular Drug Delivery Sales by Country
    • 6.1.2 North America Ocular Drug Delivery Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Ocular Drug Delivery Market Facts & Figures by Type
  • 6.3 North America Ocular Drug Delivery Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Ocular Drug Delivery by Country
    • 7.1.1 Europe Ocular Drug Delivery Sales by Country
    • 7.1.2 Europe Ocular Drug Delivery Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Ocular Drug Delivery Market Facts & Figures by Type
  • 7.3 Europe Ocular Drug Delivery Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Ocular Drug Delivery by Region
    • 8.1.1 Asia Pacific Ocular Drug Delivery Sales by Region
    • 8.1.2 Asia Pacific Ocular Drug Delivery Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Ocular Drug Delivery Market Facts & Figures by Type
  • 8.3 Asia Pacific Ocular Drug Delivery Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Ocular Drug Delivery by Country
    • 9.1.1 Latin America Ocular Drug Delivery Sales by Country
    • 9.1.2 Latin America Ocular Drug Delivery Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Ocular Drug Delivery Market Facts & Figures by Type
  • 9.3 Central & South America Ocular Drug Delivery Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Ocular Drug Delivery by Country
    • 10.1.1 Middle East and Africa Ocular Drug Delivery Sales by Country
    • 10.1.2 Middle East and Africa Ocular Drug Delivery Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Ocular Drug Delivery Market Facts & Figures by Type
  • 10.3 Middle East and Africa Ocular Drug Delivery Market Facts & Figures by Application

11 Company Profiles

  • 11.1 OCULAR THERAPEUTIX, INC
    • 11.1.1 OCULAR THERAPEUTIX, INC Corporation Information
    • 11.1.2 OCULAR THERAPEUTIX, INC Description, Business Overview and Total Revenue
    • 11.1.3 OCULAR THERAPEUTIX, INC Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 OCULAR THERAPEUTIX, INC Ocular Drug Delivery Products Offered
    • 11.1.5 OCULAR THERAPEUTIX, INC Recent Development
  • 11.2 Alimera Sciences
    • 11.2.1 Alimera Sciences Corporation Information
    • 11.2.2 Alimera Sciences Description, Business Overview and Total Revenue
    • 11.2.3 Alimera Sciences Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Alimera Sciences Ocular Drug Delivery Products Offered
    • 11.2.5 Alimera Sciences Recent Development
  • 11.3 Allergan, Plc
    • 11.3.1 Allergan, Plc Corporation Information
    • 11.3.2 Allergan, Plc Description, Business Overview and Total Revenue
    • 11.3.3 Allergan, Plc Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Allergan, Plc Ocular Drug Delivery Products Offered
    • 11.3.5 Allergan, Plc Recent Development
  • 11.4 EyeGate Pharma
    • 11.4.1 EyeGate Pharma Corporation Information
    • 11.4.2 EyeGate Pharma Description, Business Overview and Total Revenue
    • 11.4.3 EyeGate Pharma Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 EyeGate Pharma Ocular Drug Delivery Products Offered
    • 11.4.5 EyeGate Pharma Recent Development
  • 11.5 Valeant Pharmaceuticals International, Inc
    • 11.5.1 Valeant Pharmaceuticals International, Inc Corporation Information
    • 11.5.2 Valeant Pharmaceuticals International, Inc Description, Business Overview and Total Revenue
    • 11.5.3 Valeant Pharmaceuticals International, Inc Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 Valeant Pharmaceuticals International, Inc Ocular Drug Delivery Products Offered
    • 11.5.5 Valeant Pharmaceuticals International, Inc Recent Development
  • 11.6 Envisia Therapeutics
    • 11.6.1 Envisia Therapeutics Corporation Information
    • 11.6.2 Envisia Therapeutics Description, Business Overview and Total Revenue
    • 11.6.3 Envisia Therapeutics Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 Envisia Therapeutics Ocular Drug Delivery Products Offered
    • 11.6.5 Envisia Therapeutics Recent Development
  • 11.7 Clearside Biomedical
    • 11.7.1 Clearside Biomedical Corporation Information
    • 11.7.2 Clearside Biomedical Description, Business Overview and Total Revenue
    • 11.7.3 Clearside Biomedical Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 Clearside Biomedical Ocular Drug Delivery Products Offered
    • 11.7.5 Clearside Biomedical Recent Development
  • 11.8 Graybug Vision Inc
    • 11.8.1 Graybug Vision Inc Corporation Information
    • 11.8.2 Graybug Vision Inc Description, Business Overview and Total Revenue
    • 11.8.3 Graybug Vision Inc Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 Graybug Vision Inc Ocular Drug Delivery Products Offered
    • 11.8.5 Graybug Vision Inc Recent Development
  • 11.9 Taiwan Liposome Company
    • 11.9.1 Taiwan Liposome Company Corporation Information
    • 11.9.2 Taiwan Liposome Company Description, Business Overview and Total Revenue
    • 11.9.3 Taiwan Liposome Company Sales, Revenue and Gross Margin (2015-2020)
    • 11.9.4 Taiwan Liposome Company Ocular Drug Delivery Products Offered
    • 11.9.5 Taiwan Liposome Company Recent Development
  • 11.10 Santen Pharmaceutical
    • 11.10.1 Santen Pharmaceutical Corporation Information
    • 11.10.2 Santen Pharmaceutical Description, Business Overview and Total Revenue
    • 11.10.3 Santen Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
    • 11.10.4 Santen Pharmaceutical Ocular Drug Delivery Products Offered
    • 11.10.5 Santen Pharmaceutical Recent Development
  • 11.1 OCULAR THERAPEUTIX, INC
    • 11.1.1 OCULAR THERAPEUTIX, INC Corporation Information
    • 11.1.2 OCULAR THERAPEUTIX, INC Description, Business Overview and Total Revenue
    • 11.1.3 OCULAR THERAPEUTIX, INC Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 OCULAR THERAPEUTIX, INC Ocular Drug Delivery Products Offered
    • 11.1.5 OCULAR THERAPEUTIX, INC Recent Development

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Ocular Drug Delivery Market Estimates and Projections by Region
    • 12.1.1 Global Ocular Drug Delivery Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Ocular Drug Delivery Revenue Forecast by Regions 2021-2026
  • 12.2 North America Ocular Drug Delivery Market Size Forecast (2021-2026)
    • 12.2.1 North America: Ocular Drug Delivery Sales Forecast (2021-2026)
    • 12.2.2 North America: Ocular Drug Delivery Revenue Forecast (2021-2026)
    • 12.2.3 North America: Ocular Drug Delivery Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Ocular Drug Delivery Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Ocular Drug Delivery Sales Forecast (2021-2026)
    • 12.3.2 Europe: Ocular Drug Delivery Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Ocular Drug Delivery Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Ocular Drug Delivery Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Ocular Drug Delivery Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Ocular Drug Delivery Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Ocular Drug Delivery Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Ocular Drug Delivery Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Ocular Drug Delivery Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Ocular Drug Delivery Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Ocular Drug Delivery Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Ocular Drug Delivery Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Ocular Drug Delivery Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Ocular Drug Delivery Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Ocular Drug Delivery Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter’s Five Forces Analysis
  • 13.5 Primary Interviews with Key Ocular Drug Delivery Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Ocular Drug Delivery Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source

    Ocular Drug Delivery market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Ocular Drug Delivery market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

    Segment by Type, the Ocular Drug Delivery market is segmented into
    By Technology
    By Form

    Segment by Application, the Ocular Drug Delivery market is segmented into
    Hospitals
    Ambulatory Surgical Centers
    Ophthalmic Clinics
    Homecare Settings

    Regional and Country-level Analysis
    The Ocular Drug Delivery market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Ocular Drug Delivery market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
    Competitive Landscape and Ocular Drug Delivery Market Share Analysis
    Ocular Drug Delivery market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Ocular Drug Delivery business, the date to enter into the Ocular Drug Delivery market, Ocular Drug Delivery product introduction, recent developments, etc.
    The major vendors covered:
    OCULAR THERAPEUTIX, INC
    Alimera Sciences
    Allergan, Plc
    EyeGate Pharma
    Valeant Pharmaceuticals International, Inc
    Envisia Therapeutics
    Clearside Biomedical
    Graybug Vision Inc
    Taiwan Liposome Company
    Santen Pharmaceutical

    Buy now